Lung and Digestive Health: Monitoring and Care

While the light coloring and bleeding risks of Hermansky-Pudlak Syndrome (HPS) are often noticed first, the most serious long-term challenges for certain subtypes involve the lungs and the digestive tract ^[1]. For those with HPS-1, HPS-2, and HPS-4, proactive monitoring is a powerful tool for protecting your health ^[2].

Pulmonary Fibrosis: When the Lungs Scar

Pulmonary fibrosis (PF) is a condition where the delicate tissue of the lungs becomes scarred and thickened, making it difficult for oxygen to enter the bloodstream ^[3]. In HPS, this scarring tends to be progressive ^[4].

The timing of lung issues depends heavily on your subtype:

• HPS-1 and HPS-4: Lung scarring typically begins in adulthood, most often between the ages of 30 and 50 ^[4][5].
• HPS-2: This subtype is different; interstitial lung disease can sometimes begin much earlier, and has been reported in childhood ^[6].

Monitoring and Management

Because there is currently no FDA-approved medication proven to stop or reverse HPS-related lung scarring, care focuses on monitoring and support ^[2]. Drugs like pirfenidone and nintedanib are sometimes considered on a case-by-case investigational basis, but their efficacy in HPS is not established.

Standard monitoring includes serial Pulmonary Function Tests (PFTs)—specifically measuring FVC (Forced Vital Capacity) and DLCO (Diffusing Capacity for Carbon Monoxide)—to track how well your lungs are working ^[2][3]. High-Resolution CT (HRCT) scans may be used selectively under specialist direction to visualize scarring, though routine repeated scans are not automatically required for everyone ^[2].

Supportive care includes:

• Supplemental Oxygen: Used when blood oxygen levels drop, especially during exercise ^[3][7].
• Pulmonary Rehabilitation: Specialized exercise programs to improve stamina and breathing efficiency ^[3].
• Transplant Referral: If lung function shows a concerning decline, specialists will often recommend an evaluation at a lung transplant center. This referral is an evaluation and does not mean transplantation will be immediately required, but early assessment is strongly encouraged well before end-stage respiratory failure ^[2][8].

HPS-Associated Colitis

A subset of people with certain HPS subtypes (primarily HPS-1 and HPS-4, though also reported in HPS-3 and HPS-6) develop a form of Inflammatory Bowel Disease (IBD) ^[9][10]. This condition, often called HPS-colitis, behaves very much like Crohn’s disease ^[9].

Symptoms often include chronic diarrhea, abdominal pain, and hematochezia (bloody stools) ^[9]. It can appear at any age ^[9][10].

Management must be highly individualized by a gastroenterologist working with a hematologist (and sometimes an immunologist), because treatments carry distinct risks:

• Medications: Steroids, immunomodulators (like azathioprine), and anti-TNF therapies (like infliximab) are sometimes used to reduce inflammation ^[11][12]. However, these suppress the immune system, which requires careful assessment for infection risks, especially in patients with neutropenia (HPS-2).
• Surgery: In severe cases where medicine does not work, surgery to remove a portion of the bowel may be considered ^[9][13]. Surgery requires extensive hemostatic planning due to bleeding risks.

Emergency Red Flags

Some lung and GI issues in HPS require immediate medical evaluation. Seek emergency care if you experience any of the following:

• Sudden Chest Pain or Rapid Shortness of Breath: Sharp, stabbing pain in the chest, especially if it gets worse when breathing, can indicate a pneumothorax (a collapsed lung) ^[7][6].
• GI Crises: Uncontrolled bleeding (large amounts of bright red blood or black, tarry stools) or intense abdominal pain accompanied by a high fever or a very hard, bloated stomach ^{[9][14][11][10]}.